Lataa...
Emerging Use of Epidiolex (Cannabidiol) in Epilepsy
The first plant-derived, purified pharmaceutical-grade cannabidiol (CBD) medication, Epidiolex, was approved in the United States by the FDA on June 25, 2018. Its approval for patients ≥ 2 years of age with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS) markedly altered the treatment of medic...
Tallennettuna:
| Julkaisussa: | J Pediatr Pharmacol Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Pediatric Pharmacy Advocacy Group
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7439947/ https://ncbi.nlm.nih.gov/pubmed/32839652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-25.6.485 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|